These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4161911)

  • 21. [Results of the inoculation test of measles vaccine. 1. The result of measles-attenuated live virus vaccine].
    Santo K
    Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):332-43. PubMed ID: 4168846
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of two live measles vaccines in virgin populations in arctic Greenland. Clinical and serological reactions in children and adults.
    Mordhorst CH; Tulinius S; von Magnus H
    Dan Med Bull; 1968 Nov; 15(9):263-70. PubMed ID: 4102838
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fever reaction and the effect on antibody formation of vaccination with commercially available KL measles vaccine, with special reference take-rate of live vaccine and need for additional immunization].
    Santo K; Tatsumi H; Kato K; Hanaya T; Abe S
    Nihon Shonika Gakkai Zasshi; 1969 Apr; 73(4):594-9. PubMed ID: 5817479
    [No Abstract]   [Full Text] [Related]  

  • 24. Measles (rubeola) in previously immunized children.
    Baratta RO; Ginter MC; Price MA; Walker JW; Skinner RG; Prather EC; David JK
    Pediatrics; 1970 Sep; 46(3):397-402. PubMed ID: 4195394
    [No Abstract]   [Full Text] [Related]  

  • 25. Atypical measles in children previously immunized with attenuated measles virus vaccines.
    Cherry JD; Feigin RD; Lobes LA; Shackelford PG
    Pediatrics; 1972 Nov; 50(5):712-7. PubMed ID: 5084185
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
    Chiarini A; Brancato P; Sinatra A
    Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on further attenuated liver measles vaccine. VI. Clinical and serological follow-up one year after vaccination.
    Ueda S; Takahashi M; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):247-51. PubMed ID: 4258008
    [No Abstract]   [Full Text] [Related]  

  • 28. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.
    Ueda K; Hashiguchi K; Nakashima F; Ueda S; Takahashi M
    Biken J; 1981 Sep; 24(3):119-22. PubMed ID: 7337678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; Stokes J; Hilleman MR
    Pediatrics; 1973 Mar; 51(3):467-75. PubMed ID: 4707864
    [No Abstract]   [Full Text] [Related]  

  • 30. [Virologic and clinical observations after active measles vaccination. 2].
    Haas R; Vivell O; Buentello-Malo L; Reiss G; Berning D
    Dtsch Med Wochenschr; 1966 Apr; 91(13):569-74. PubMed ID: 5930702
    [No Abstract]   [Full Text] [Related]  

  • 31. Notes on the effect of measles and measles vaccine in a virgin-soil population of South American Indians.
    Neel JV; Centerwall WR; Chagnon NA; Casey HL
    Am J Epidemiol; 1970 Apr; 91(4):418-29. PubMed ID: 4192799
    [No Abstract]   [Full Text] [Related]  

  • 32. [Specific anti-measles prophylaxis in Rumania. 3. Comparative study of some live attenuated virus vaccines].
    Cajal N; Cepleanu M; Cernescu C; Sorodoc Y
    Stud Cercet Inframicrobiol; 1969; 20(4):275-85. PubMed ID: 5371258
    [No Abstract]   [Full Text] [Related]  

  • 33. Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus.
    Willis MF; Warburton MF
    Med J Aust; 1974 May; 1(20):789-93. PubMed ID: 4853112
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.
    Ueda S; Okuno Y; Sakamoto Y; Sangkawibha N; Tuchinda P
    Biken J; 1974 Mar; 17(1):11-20. PubMed ID: 4854462
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.
    Bellanti JA; Sanga RL; Klutinis B; Brandt B; Artenstein MS
    N Engl J Med; 1969 Mar; 280(12):628-33. PubMed ID: 4179401
    [No Abstract]   [Full Text] [Related]  

  • 37. MEASLES VACCINATION. II. ANTIBODY TITERS 8 TO 9 MONTHS AFTER VACCINATION WITH AN INACTIVATED VACCINE.
    NORRBY E; CARLSTROEM G; LAGERCRANTZ R; GARD S
    Acta Paediatr (Stockh); 1964 Nov; 53():533-40. PubMed ID: 14225879
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical immunoserological study of combined innoculation of inactivated and live measles vaccines].
    Yamazaki Y
    Nihon Shonika Gakkai Zasshi; 1969 May; 73(5):644-55. PubMed ID: 5817193
    [No Abstract]   [Full Text] [Related]  

  • 39. MEASLES VACCINATION IN INFANTS. USE OF KILLED-LIVE COMBINATIONS.
    ALEXANDER ER; BANSMER CM; HARRIS ES; GILES B; SPARKS MJ
    Am J Dis Child; 1964 Nov; 108():470-8. PubMed ID: 14208407
    [No Abstract]   [Full Text] [Related]  

  • 40. [Time of the appearance of immunity to measles after the administration of a live measles vaccine].
    Revenok ND
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():355-60. PubMed ID: 5860953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.